CoChat

Inhibitory cross‐talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress‐induced insulin resistance in skeletal muscle

Open access
Hwang, Seung‐Lark, Jeong, Yong‐Tae, Li, Xian, Kim, Yong Deuk, Lu, Yue, Chang, Young‐Chae, Lee, In‐Kyu, Chang, Hyeun Wook · 2013 · British Journal of Pharmacology
Cited by 90

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Background and Purpose: Endoplasmic reticulum (ER) stress has been implicated in the pathogeneses of insulin resistance and type 2 diabetes, and extracellular signal‐regulated kinase (ERK) antagonist is an insulin sensitizer that can restore muscle insulin responsiveness in both tunicamycin‐treated muscle cells and type 2 diabetic mice. The present study was undertaken to determine whether the chemical or genetic inhibition ER stress pathway targeting by ERK results in metabolic benefits in muscle cells. Experimental Approach: ER stress was induced in L 6 myotubes using tunicamycin (5 μg·mL−1) or thapsigargin (300 nM) and cells were transfected with siRNA ERK or AMPK α2. Changes in ER stress and in the ERK and AMPK signalling pathways were explored by W estern blotting. The phosphorylation levels of insulin receptor substrate 1 were analysed by immunoprecipitation and using glucose uptake assay. Key Results: ER stress dampened insulin‐stimulated signals and glucose uptake, whereas treatment with the specific ERK inhibitor U 0126 (25 μM) rescued impaired insulin signalling via AMPK activation. In db/db mice, U 0126 administration decreased markers of insulin resistance and increased the phosphorylations of A kt and AMPK in muscle tissues. Conclusions and Implications: Inhibition of ERK signalling pathways by a chemical inhibitor and knockdown of ERK improved AMPK and A kt signallings and reversed ER stress‐induced insulin resistance in L 6 myotubes. These findings suggest that ERK signalling plays an important role in the regulation of insulin signals in muscle cells under ER stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12124

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 90

Metadata

Authors
Hwang, S., Jeong, Y., Li, X., Kim, Y. D., Lu, Y., Chang, Y., Lee, I., & Chang, H. W.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2013-04-12
Volume
169
Issue
1
Pages
69-81
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1521170528
Cited by
90
References
22
FWCI
4.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.